Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers — Roni Manyevitch (2018) | RDL Network
Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers
Article 2018 en
Authors
RM
Roni Manyevitch
MP
Matthew Protas
SS
Sean Scarpiello
Abstract
1 min read
This study provides proof of concept for the use of meta-analysis validation of AD hypotheses, specifically via robust evidence for the cholinergic hypothesis of AD. Our data disagree with the other synaptic hypotheses of glutamate excitotoxicity and GABAergic resistance to neurodegeneration, given observed unchanged glutamate levels and decreased GABA levels. With regards to metabolic hypotheses, the data supported upregulation of anaerobic glycolysis, pentose phosphate pathway (glutathione), and anaplerosis of the tricarboxylic acid cycle using glutamate. Future applications of meta-analysis indicate the possibility of further in silico evaluation and generation of novel hypotheses in the AD field.
Brittany Bass, Sean Scarpiello, Roni Manyevitch, Matthew Protas, Anthony Nanajian, Matthew Chang, Stefani Thompson, Neil Khoury, Marisa Deliso, George Perry, Margit Trotz, D. Blaine Moore, Jan Friederich, Vivek Nuguri, Ian Murray
Ingo Kilimann, Michel J. Grothe, Helmut Heinsen, Eduardo Joaquim Lopes Alho, Giovanni B. Frisoni, Arun L.W. Bokde, Andreas Fellgiebel, Massimo Filippi, Harald Hampel, Stefan Klöppel, Stefan Teipel
Discussion(0)
No comments yet. Be the first to comment.